MeSH tree: C04.557.465.625.600.380
Researchers from The University of Texas MD Anderson Cancer Center have found that simultaneously blocking two key "don't eat me signals" found in cancer cells heightens the immune response and sensitizes tumors to immunotherapy ...
Mar 13, 2026
0
1
High-grade gliomas, especially glioblastoma (GBM) and others, remain among the most aggressive brain cancers, with few effective treatment options after the tumor recurs. Even with maximal surgical resection, radiotherapy, ...
Mar 13, 2026
0
1
In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug discovery. The focus is on the targeted modulation of certain intracellular signaling proteins as a strategy ...
Mar 6, 2026
0
0
Research uncovering the origin of pineoblastoma, a rare pediatric brain tumor, has also revealed a dependency across multiple brain tumor types that share a similar molecular program. Scientists at St. Jude Children's Research ...
Mar 5, 2026
0
0
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel ...
Mar 4, 2026
0
0
CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, which account for over 85% of all cancers. Columbia researchers have now found that a new type ...
Feb 26, 2026
0
1
High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients with recurrent high-grade astrocytoma typically ...
Feb 26, 2026
0
0
A study led by St. Jude Children's Research Hospital assessed cognitive and communication abilities in children treated for the brain tumor ependymoma to understand the impact of treatment better. They found that radiation ...
Feb 23, 2026
0
0
A team led by investigators at Mass General Brigham and Dana-Farber Cancer Institute has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can ...
Feb 11, 2026
0
80
For the first time, researchers have identified a previously unrecognized metabolic defense mechanism in aggressive brain tumors: a sugar-rich shield that surrounds tumor cells and protects them against a particularly destructive ...
Feb 11, 2026
0
3
